Effect of Dietary Inulin Supplementation on Inflammation of Pouch Mucosa in Patients With an Ileal Pouch-Anal Anastomosis

Welters, Carlo F. M.; Heineman, Erik; Thunnissen, Erik; Bogaard, A. E. J. M. van den; Soeters, Peter B.; Baeten, C. G. M. I.

doi:10.1007/s10350-004-6257-2

Cited by 252 publications

(159 citation statements)

References 34 publications

Supporting

Mentioning

144

Contrasting

Unclassified

Order By: Relevance

“…This study showed a significant reduction of the fecal inflammatory marker calprotectin in prebiotic-treated patients after 1 week compared to the placebo group, suggesting that these prebiotics were able to reduce chronic intestinal inflammation. 85 Welters et al 86 performed a crossover study in 24 patients with chronic pouchitis after colectomy for UC. The patients were given 24 g daily of inulin or placebo for 3 weeks.…”

Section: Prebiotics In Human Ibd Prebioticsmentioning

confidence: 99%

Prebiotics in Chronic Intestinal Inflammation

Langen

Dieleman

2009

Inflammatory Bowel Diseases

163

107

View full text Add to dashboard Cite

Prebiotics are nondigestible fermentable fibers that are reported to have health benefits for the host. Older as well as more recent studies show beneficial effects in experimental colitis and lately also in human inflammatory bowel diseases (IBD), such as Crohn's disease, ulcerative colitis, and chronic pouchitis. In this review we give an overview of the benefits of prebiotics in rodent IBD models and in IBD patients and discuss their possible protective mechanisms. Commensal intestinal bacteria induce and perpetuate chronic intestinal inflammation, whereas others are protective. However, most of the current medications are directed against the exaggerated proinflammatory immune response of the host, some of them toxic and costly. Feeding prebiotics changes the composition of the intestinal microflora toward more protective intestinal bacteria and alters systemic and mucosal immune responses of the host. Therapy for IBD targeting intestinal bacteria and their function is just emerging. Prebiotics have the promise to be relatively safe, inexpensive, and easy to administer. Unraveling their protective mechanisms will help to develop rational applications of prebiotics. However, the initial promising results with dietary prebiotics in preclinical trials as well as small studies in human IBD will need to be confirmed in large randomized controlled clinical trials. Keywords ulcerative colitis; Crohn's disease; prebiotics; bifidobacteria; lactobacilli The incidence and prevalence of chronic inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are increasing in the developed northern hemisphere. Bernstein et al 1 recently published data that showed that Canada has the highest incidence and prevalence of CD thus far reported. The incidence rate for CD ranged from 8.8-20.2 per 100,000 and the prevalence ranged from 161-319 per 100,000. The incidence and prevalence of UC was lower, ranging from 9.9-19.5 and 162-249 per 100,000, respectively. Approximately 0.5% of the Canadian population has IBD. Several studies concerning the pathogenesis of IBD indicate that a combination of factors such as genetic susceptibility, intestinal microflora, dietary factors, intestinal barrier dysfunction, and an abnormal immune response to intestinal bacteria lead to chronic intestinal inflammation. CIHR Author Manuscript CIHR Author Manuscript CIHR Author Manuscript Current IBD TherapeuticsThe current medical armamentarium to treat UC and CD consists of 5-aminosalicylic acid (ASA) compounds, corticosteroids, azathioprine/6-mercaptopurine, methotrexate, and cyclosporine. Recently several biologics have been added to this list. 5 Most patients respond well to these therapies, but for some patients it is still inadequate and/or induces intolerable and serious side effects. In addition, the current therapies are mostly directed against the overly aggressive adaptive immune response of the host, but fail to correct potential environmental triggers such as the intestinal microflora that induces a...

show abstract

Section: Prebiotics In Human Ibd Prebioticsmentioning

confidence: 99%

Prebiotics in Chronic Intestinal Inflammation

Langen

Dieleman

2009

Inflammatory Bowel Diseases

163

107

View full text Add to dashboard Cite

show abstract

“…The prebiotic inulin and a combination of the probiotic organisms Lctb acidophilus La-5, Lctb delbruckii subsp. bulgaricus, Bfdbm Bb-12, and Streptococcus thermophilus significantly reduced inflammation [64]. The effect was enhanced by combination with metronidazole, suggesting a synergistic effect of the combination of anti-and probiotics in the treatment of experimental colitis [65].…”

Section: Iva-probiotic Effect In Animal Experimental Ibd Modelsmentioning

confidence: 90%

Probiotics for Autoimmune Diseases: Is There a Benefit?

Özdemir¹,

Göksu-Erol²

2012

Contemporary Pediatrics

View full text Add to dashboard Cite

“…43 Similarly, germinated barley foodstuffs, including Ispaghula husk, have been shown to have some effect on mild to moderate IBD, whereas inulin supplementation leads to increased butyrate and lower levels of Bacteroides fragilis and Bacteroidetes in the feces of patients with chronic pouchitis. 44 Moreover, studies in migrant populations suggest individuals who move from Southeast Asia to western countries have a higher risk of developing IBD; this effect is likely secondary to changes in dietary habits and resultant effects on gut microbiota in genetically susceptible individuals. 45 .…”

Section: Gut Microbiota In Inflammatory Bowel Diseasementioning

confidence: 99%

A clinical primer of the role of gut microbiome in health and disease

Yang¹

2015

View full text Add to dashboard Cite

Effect of Dietary Inulin Supplementation on Inflammation of Pouch Mucosa in Patients With an Ileal Pouch-Anal Anastomosis

Abstract: Enteral inulin supplementation leads to a decrease of inflammation-associated factors and to a reduction of inflammation of pouch mucosa.

Cited by 252 publications

References 34 publications

Prebiotics in Chronic Intestinal Inflammation

Prebiotics in Chronic Intestinal Inflammation

Probiotics for Autoimmune Diseases: Is There a Benefit?

A clinical primer of the role of gut microbiome in health and disease

Contact Info

Product

Resources

About